Family Medicine · Brooklyn, NY
NPI
1972684751
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2814 Clarendon Rd
Brooklyn, NY, 11226
Phone (718) 469-7363
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
2,180 services
Medicare patients, 2024
204
Average age 75
Drug cost, 2024
$2.9M
21,430 prescriptions
Company payments, 2025
$1,998
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mayya Fasolya was code 99212 (office e&m - established), 537 times for 168 patients. In total Mayya Fasolya billed 2,180 services in 31 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99212 Office E&M - Established | Office | 537 | 168 | $48.78 | $26K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 369 | 99 | $27.52 | $10K |
| 99213 Office E&M - Established | Office | 349 | 167 | $77.84 | $27K |
| 36415 Venipuncture Blood Collection | Office | 248 | 156 | $8.65 | $2,145 |
| 93000 Electrocardiogram | Office | 139 | 115 | $11.98 | $1,666 |
| 82962 Clinical Chemistry | Office | 131 | 48 | $3.21 | $421 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 108 | 108 | $21.03 | $2,271 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 93 | 93 | $142.46 | $13K |
| 99442 Telephone Services | Office | 83 | 59 | $75.40 | $6,258 |
| 96365 Intravenous Infusion, Hydration | Office | 37 | 14 | $55.29 | $2,046 |
| 99406 Behavioral Health Services | Office | 25 | 15 | $16.07 | $402 |
| 99203 Office E&M - New | Office | 11 | 11 | $98.63 | $1,085 |
By year: 2022 $131K for 2,579 services; 2023 $115K for 2,332 services; 2024 $96K for 2,180 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 248 | 156 | $8.65 | $2,145 |
| 82962 Clinical Chemistry | 131 | 48 | $3.21 | $421 |
Medicare prescription drug claims, 2024
In 2024, the drug Mayya Fasolya prescribed most often to Medicare patients was Diclofenac Sodium, with 780 prescriptions and refills. In total Mayya Fasolya wrote 21,430 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 780 | 818 | 98 | $172K |
| Amlodipine Besylate Generic | 666 | 902 | 107 | $1,331 |
| Vascepa Icosapent Ethyl | 654 | 677 | 86 | $222K |
| Dexlansoprazole Dr Dexlansoprazole | 508 | 566 | 62 | $88K |
| Atorvastatin Calcium Generic | 481 | 655 | 72 | $1,982 |
| Rosuvastatin Calcium Generic | 476 | 592 | 72 | $5,972 |
| Omeprazole Generic | 459 | 578 | 70 | $2,120 |
| Metoprolol Tartrate Generic | 430 | 524 | 65 | $1,220 |
| Simvastatin Generic | 425 | 591 | 63 | $1,391 |
| Metoprolol Succinate Generic | 419 | 493 | 54 | $3,489 |
| Famotidine Generic | 381 | 440 | 66 | $2,324 |
| Fluticasone Propionate Generic | 355 | 367 | 75 | $3,113 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 351 | 391 | 58 | $14K |
| Chlorhexidine Gluconate Generic | 346 | 346 | 63 | $1,702 |
| Linzess Linaclotide | 293 | 309 | 37 | $160K |
Brand drugs: 5,192 claims; generic drugs: 15,940 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mayya Fasolya $1,998 ($1,998 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $518.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $518 |
| Aimmune Therapeutics, Inc. | 6 | $181 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $162 |
| Astellas Pharma US Inc 4503.T | 6 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 7 | $128 |
| Axsome Therapeutics, Inc. AXSM | 4 | $122 |
| GlaxoSmithKline, LLC. GSK | 4 | $110 |
| Amgen Inc. AMGN | 4 | $91.17 |
| Novo Nordisk Inc NVO | 3 | $66.61 |
| Pfizer Inc. PFE | 3 | $64.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.